Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor

Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, Kimon C. Kanelakis, Xiaodong Wu, Peter V. Haug, Wen Yan, Andrew Young, Hong Hua, Juliet C. Hart, Da-Thao Tran, Hariharan Venkatesan, Mark D. Rosen, Hillary M. Peltier, Kia Sepassi, Michele C. Rizzolio, Scott D. Bembenek, Tara Mirzadegan, Michael H. Rabinowitz and Nigel P. Shankley
Molecular Pharmacology June 2011, 79 (6) 910-920; DOI: https://doi.org/10.1124/mol.110.070508
Terrance D. Barrett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather L. Palomino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theresa I. Brondstetter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimon C. Kanelakis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaodong Wu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter V. Haug
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen Yan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Young
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Hua
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juliet C. Hart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Da-Thao Tran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hariharan Venkatesan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark D. Rosen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hillary M. Peltier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kia Sepassi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele C. Rizzolio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott D. Bembenek
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tara Mirzadegan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael H. Rabinowitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigel P. Shankley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 79 no. 6 910-920
DOI 
https://doi.org/10.1124/mol.110.070508
PubMed 
21372172

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received December 10, 2010
  • Accepted March 3, 2011
  • Published online May 17, 2011.

Article Versions

  • Earlier version (March 3, 2011 - 07:01).
  • Earlier version (March 10, 2011 - 05:57).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Terrance D. Barrett,
  2. Heather L. Palomino,
  3. Theresa I. Brondstetter,
  4. Kimon C. Kanelakis,
  5. Xiaodong Wu,
  6. Peter V. Haug,
  7. Wen Yan,
  8. Andrew Young,
  9. Hong Hua,
  10. Juliet C. Hart,
  11. Da-Thao Tran,
  12. Hariharan Venkatesan,
  13. Mark D. Rosen,
  14. Hillary M. Peltier,
  15. Kia Sepassi,
  16. Michele C. Rizzolio,
  17. Scott D. Bembenek,
  18. Tara Mirzadegan,
  19. Michael H. Rabinowitz and
  20. Nigel P. Shankley
  1. Cardiovascular Metabolic Team, Johnson & Johnson Pharmaceutical Research and Development, LLC, San Diego, California
  1. Address correspondence to:
    Dr. Terrance D. Barrett, Cardiovascular Metabolic Research, Johnson and Johnson Pharmaceutical Research and Development LLC, 3210 Merryfield Row, San Diego, CA 92121. E-mail: tbarret1{at}its.jnj.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: March 2011 to March 2023

AbstractFullPdf
Mar 20113380375
Apr 20111300198
May 201157727119
Jun 20116314573
Jul 20111352665
Aug 20111222962
Sep 2011841563
Oct 2011792363
Nov 2011872568
Dec 2011521137
Jan 2012602872
Feb 20121002163
Mar 20121121757
Apr 2012861433
May 2012881736
Jun 2012531859
Jul 2012343159
Aug 2012493665
Sep 2012564550
Oct 2012263460
Nov 2012444383
Dec 2012363275
Jan 2013686073
Feb 2013395048
Mar 2013444461
Apr 2013455752
May 2013394454
Jun 2013133630
Jul 2013465553
Aug 201372933
Sep 2013263134
Oct 2013253938
Nov 2013132524
Dec 2013112330
Jan 2014153435
Feb 2014264130
Mar 2014173036
Apr 2014104434
May 201495122
Jun 2014165335
Jul 2014427016
Aug 2014144126
Sep 2014153425
Oct 2014367032
Nov 2014463836
Dec 2014312916
Jan 2015103222
Feb 2015154823
Mar 2015303229
Apr 2015293126
May 2015203218
Jun 2015235032
Jul 2015254536
Aug 2015224333
Sep 2015214632
Oct 2015123535
Nov 2015144326
Dec 2015163658
Jan 2016332937
Feb 201693448
Mar 2016363742
Apr 2016151826
May 2016152143
Jun 2016132330
Jul 2016212027
Aug 2016352333
Sep 2016221832
Oct 201632737
Nov 201632227
Dec 201602833
Jan 201713024
Feb 201725333
Mar 2017117427
Apr 2017114931
May 2017104442
Jun 201762625
Jul 2017112736
Aug 2017123637
Sep 201792730
Oct 2017112738
Nov 2017174767
Dec 2017123539
Jan 2018174137
Feb 2018204053
Mar 2018194542
Apr 2018224964
May 201833620
Jun 201872710
Jul 201832015
Aug 201802114
Sep 201872111
Oct 201833520
Nov 201842311
Dec 2018401517
Jan 201950412
Feb 201936410
Mar 201931114
Apr 201939610
May 20194318
Jun 201917414
Jul 201931110
Aug 201926103
Sep 201950510
Oct 2019221012
Nov 20193032
Dec 20193346
Jan 20202333
Feb 20201842
Mar 20202752
Apr 20202452
May 20203222
Jun 20202861
Jul 20202676
Aug 20201259
Sep 20202055
Oct 20201738
Nov 20201333
Dec 20205184
Jan 202145108
Feb 20215089
Mar 202153148
Apr 20215233
May 202131126
Jun 202146126
Jul 202146814
Aug 20213382
Sep 20212625
Oct 20211922
Nov 20212958
Dec 20212456
Jan 20223255
Feb 20223152
Mar 20224544
Apr 20223412
May 20224263
Jun 20225054
Jul 20223959
Aug 20224224
Sep 20223274
Oct 20223234
Nov 20223832
Dec 20224021
Jan 20232813
Feb 20235186
Mar 20232541

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 79 (6)
Molecular Pharmacology
Vol. 79, Issue 6
1 Jun 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor

Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, Kimon C. Kanelakis, Xiaodong Wu, Peter V. Haug, Wen Yan, Andrew Young, Hong Hua, Juliet C. Hart, Da-Thao Tran, Hariharan Venkatesan, Mark D. Rosen, Hillary M. Peltier, Kia Sepassi, Michele C. Rizzolio, Scott D. Bembenek, Tara Mirzadegan, Michael H. Rabinowitz and Nigel P. Shankley
Molecular Pharmacology June 1, 2011, 79 (6) 910-920; DOI: https://doi.org/10.1124/mol.110.070508

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor

Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, Kimon C. Kanelakis, Xiaodong Wu, Peter V. Haug, Wen Yan, Andrew Young, Hong Hua, Juliet C. Hart, Da-Thao Tran, Hariharan Venkatesan, Mark D. Rosen, Hillary M. Peltier, Kia Sepassi, Michele C. Rizzolio, Scott D. Bembenek, Tara Mirzadegan, Michael H. Rabinowitz and Nigel P. Shankley
Molecular Pharmacology June 1, 2011, 79 (6) 910-920; DOI: https://doi.org/10.1124/mol.110.070508
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Pharmacological characterization of the human α6β4 nAChR
  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics